These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10813658)

  • 1. Polyclonal antibodies to a fluorescent 4-hydroxy-2-nonenal (HNE)-derived lysine-lysine cross-link: characterization and application to HNE-treated protein and in vitro oxidized low-density lipoprotein.
    Xu G; Liu Y; Sayre LM
    Chem Res Toxicol; 2000 May; 13(5):406-13. PubMed ID: 10813658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine.
    Tsai L; Szweda PA; Vinogradova O; Szweda LI
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):7975-80. PubMed ID: 9653125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
    Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
    Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
    Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
    Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
    Chen Q; Esterbauer H; Jürgens G
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore.
    Itakura K; Oya-Ito T; Osawa T; Yamada S; Toyokuni S; Shibata N; Kobayashi M; Uchida K
    FEBS Lett; 2000 May; 473(2):249-53. PubMed ID: 10812084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Hydroxy-2-nonenal-trapping ELISA: direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins.
    Uchida K; Osawa T; Hiai H; Toyokuni S
    Biochem Biophys Res Commun; 1995 Jul; 212(3):1068-73. PubMed ID: 7626094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies.
    Uchida K; Itakura K; Kawakishi S; Hiai H; Toyokuni S; Stadtman ER
    Arch Biochem Biophys; 1995 Dec; 324(2):241-8. PubMed ID: 8554315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins.
    Kaur K; Salomon RG; O'Neil J; Hoff HF
    Chem Res Toxicol; 1997 Dec; 10(12):1387-96. PubMed ID: 9437530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Hydroperoxy-2-nonenal is not just an intermediate but a reactive molecule that covalently modifies proteins to generate unique intramolecular oxidation products.
    Shimozu Y; Hirano K; Shibata T; Shibata N; Uchida K
    J Biol Chem; 2011 Aug; 286(33):29313-29324. PubMed ID: 21690609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE.
    Al-Shobaili HA; Al Robaee AA; Alzolibani AA; Rasheed Z
    Dis Markers; 2012; 33(1):19-34. PubMed ID: 22710866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
    Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.
    Virella G; Koskinen S; Krings G; Onorato JM; Thorpe SR; Lopes-Virella M
    Clin Immunol; 2000 May; 95(2):135-44. PubMed ID: 10779407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins.
    Waeg G; Dimsity G; Esterbauer H
    Free Radic Res; 1996 Aug; 25(2):149-59. PubMed ID: 8885333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of lipid peroxidation-derived protein epitopes in the porcine corpus luteum.
    Brannian JD; Zhao Y; Burbach JA
    Biol Reprod; 1997 Dec; 57(6):1461-6. PubMed ID: 9408255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques.
    Salomon RG; Kaur K; Podrez E; Hoff HF; Krushinsky AV; Sayre LM
    Chem Res Toxicol; 2000 Jul; 13(7):557-64. PubMed ID: 10898587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
    Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
    Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid cross-linking of proteins by 4-ketoaldehydes and 4-hydroxy-2-alkenals does not arise from the lysine-derived monoalkylpyrroles.
    Xu G; Liu Y; Kansal MM; Sayre LM
    Chem Res Toxicol; 1999 Sep; 12(9):855-61. PubMed ID: 10490508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies.
    Malle E; Hazell L; Stocker R; Sattler W; Esterbauer H; Waeg G
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):982-9. PubMed ID: 7541296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein.
    Jürgens G; Ashy A; Esterbauer H
    Biochem J; 1990 Jan; 265(2):605-8. PubMed ID: 1689148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.